Delivery Order SPE2DX15D3404-SPE2DX24F1DFB

Award Date 7/25/24
Potential Completion Date 7/26/24
Potential Value $1.7K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,230.26, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Prolia 60 mg/ml syringes, a specialty pharmaceutical product, and does not have a set-aside designation. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Prolia 60 mg/ml syringes. The contract, valued at $51,605.33, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $31,381.56, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Prolia 60 mg/ml syringes, a pharmaceutical product, with a period of performance through July 15, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $24,871.44, is for the delivery of Prolia 60 mg/ml syringes. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award is for the supply of Prolia 60 mg/ml syringes to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,509.10, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a...
This federal contract award is for the delivery of Prolia 60 mg/ml syringes to the Defense Logistics Agency (DLA). The $1,743.42 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a March 11, 2024 completion date and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $11,260.68 firm fixed-price delivery order is for the supply of Prolia 60 mg/mL syringes. The award has an ultimate completion date of September 27, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,428.70, is for the delivery of Prolia 60 mg/ml syringes. It is a firm fixed-price delivery order contract with an ultimate completion date of April 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of Prolia 60 mg/mL syringes. The single-award contract has a ceiling value of $45,818.29 and runs through November 1, 2023. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award, with a ceiling value of $3,572.59, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Prolia 60 mg/ml syringes, a pharmaceutical product, and is a Firm Fixed Price Delivery Order with a performance period ending on May 7, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies...
  • SPE2DX15D3404
    Indefinite Delivery Contract
  • SPE2DX15D3404-SPE2DX24F1DFB
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, worth $1,743.42, is for the delivery of Prolia 60 mg/mL syringes. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer for Amerisourcebergen's federal contracting activities. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is scheduled for completion by July 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply critical pharmaceutical and medical products to various government agencies and healthcare programs.

Generated 10/27/24, 3:15 AM